Literature DB >> 31660495

The conundrum of endovascular common femoral artery treatment: a case report of lithoplasty as a viable solution.

Carlo Trani1,2, Giulio Russo1,2, Cristina Aurigemma1,2, Francesco Burzotta1,2.   

Abstract

BACKGROUND: Highly calcific stenosis located in common femoral artery (CFA) represents a difficult target for endovascular treatment due to the possible need for stent implantation in that area. CASE
SUMMARY: A 63-year-old man with history of coronary artery disease and previous multiple percutaneous transluminal angioplasties for peripheral artery disease (PAD) was admitted for recent onset left lower limb pain at rest with severe activity restriction (Leriche-Fontaine Class III and Rutherford Class III-IV). The angio-computed tomography scan showed a highly calcific stenosis of left CFA. The patient underwent lithoplasty balloon angioplasty followed by drug-eluting balloon inflation with excellent angiographic result and complete blood flow restoration. No procedural complications occurred. DISCUSSION: Highly calcified stenosis in PAD represents a huge challenge for endovascular treatment as not all lower extremity arteries are suitable for stenting because of compressive and torsional forces associated with stent fracture and restenosis. Lithoplasty is a new technology allowing effective blood flow restoration while minimizing vessel injury.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Case report; Common femoral artery; Highly calcified vessels; Lithoplasty; Peripheral artery disease

Year:  2019        PMID: 31660495      PMCID: PMC6764558          DOI: 10.1093/ehjcr/ytz122

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Learning points

Highly calcific stenosis located in common femoral artery (CFA) represents a huge challenge for endovascular treatment. Stent positioning in CFA may be limited by the compressive or torsional forces leading to stent fracture and/or restenosis. Lithoplasty balloon angioplasty is an effective treatment for calcific vessels and may represent a safe tool also for CFA.

Introduction

Endovascular approach has become the first choice treatment for lower extremity artery disease (LEAD), as recommended by the European Society of Cardiology guidelines on the diagnosis and treatment of peripheral artery disease (PAD). However, common femoral artery (CFA) still represents an almost forbidden target for endovascular treatment due to the reluctance to implant a stent in that area if needed. Moreover, highly calcified lesions represent a challenging subset as technical success and patency rates are poor, affecting both short- and long-term outcome. Circumferential distribution of calcium is the most negative influencing factor and increases the occurrence of flow-limiting dissections and acute vessel recoil after percutaneous transluminal angioplasty (PTA). Furthermore, stenting itself may be impaired due to subexpansion, malapposition, and fractures. Directional atherectomy followed by drug-eluting balloon (DEB) inflation showed positive results in small studies,, although data are still controversial., Alternatively, scoring balloon has been demonstrated to be safe and effective for both femoropopliteal and infrapopliteal lesions, but data are still limited., Recently, a new device, the Shockwave Medical Peripheral Lithoplasty System, has demonstrated its safety and efficacy in the treatment of calcified, stenotic infrainguinal peripheral arteries. It integrates two functions: the intermittent pulsatile mechanical energy of lithotripsy disrupt the calcium; and the integrated balloon dilates the lesion restoring the blood flow. It has been tested in a two-phase, single arm, prospective, multicentre study, DISRUPT PAD I and II where high rates of procedural success, patency, and freedom from target lesion revascularization at 30 days and at 6 months were reported. As regards safety outcomes no vascular complications occurred and no stents were implanted. Distal embolic filters were used in six patients and thrombus was found in only one filter. Consequently, it may play an important role in severely calcific LEAD management.

Case presentation

A 63-year-old man with history of coronary artery disease treated by coronary artery bypass graft was admitted for recent onset left lower limb pain at rest with severe activity restriction (Leriche-Fontaine Class III and Rutherford Class III–IV). He had already undergone PTA with stent implantation on the left superficial femoral artery several years before. An angio-computed tomography was performed showing highly calcific stenotic left CFA, (Figure A and B). Despite the high calcium burden no severe calcific stenosis was found on the right side. After in-depth discussion with the patient and upon his strong preference, a decision to attempt endovascular treatment was taken. Patient gave inform consent.
Figure 1

(A and B) Computed tomography scan image before treatment.

(A and B) Computed tomography scan image before treatment.

Access site

Shockwave balloons from 3.5 to 6 mm are 6-Fr introducer sheath-compatible with 110 cm length so a right femoral approach with crossover technique was selected. In order to increase precision, ultrasonographic guidance was adopted for the right common femoral puncture. A 6-Fr sheath was placed and left common iliac artery access was obtained through a Judkins right guiding catheter. A subtraction angiography of the left iliac-femoral axis was then performed confirming highly calcific stenosis of the CFA (Figure ).
Figure 2

Common femoral artery angiogram.

Common femoral artery angiogram.

Angioplasty technique

Severely calcific stenosis was crossed with 300 cm Choice PT Extra-Support guidewire (Boston Scientific). Lithotripsy catheter (Shockwave Medical Inc.) was advanced to the lesion site, so the manufacturer’s instructions were followed: lithoplasty balloon (6 × 60 mm) inflation to 4 atm (Figure ).
Figure 3

Lithoplasty balloon inflation in common femoral artery.

Shockwave treatment (30 pulses). Lithoplasty balloon deflation in order to re-establish blood flow (30 s). Further lithoplasty balloon inflation to 6 atm (30 s). The same sequence was repeated for six times for a total of 180 pulses in the same segment. Lithoplasty balloon inflation in common femoral artery. After the entire shockwave treatment was completed an angiogram was performed in order to assess post-intervention result (Figure ). After calcifications disruption, the lesion was finally dilated with a 7 × 60 mm DEB and the final arteriogram showed a good angiographic final result with completely restored flow and no residual vascular calcium.
Figure 4

Final angiography.

Final angiography. The patient was discharged the day after the procedure and after 9-month follow-up, no symptoms/activity restriction were reported.

Discussion

Although the true prevalence of vascular calcification in symptomatic PAD patients may vary a lot, we know that it represents a significant challenge for current endovascular device strategies. Indeed, it increases the procedure-related adverse events from early elastic recoil to dissections, perforations, and embolization, which, in some cases, lead to bailout stenting. However, not all lower extremity arteries are suitable for stenting as subject to compressive or torsional forces and consequently associated with stent fracture and restenosis. In this perspective, the use of innovative techniques may help in the treatment of severely calcific lesions. Lithotripsy is a well-established treatment adopted for calcified renal calculi, in which calcifications are fragmented by high-power acoustic shockwaves. Lithoplasty is a new technology based on lithotripsy where the circumferential pulsatile energy disrupting the calcified plaque is combined with the balloon inflation force. It is effective to restore blood flow into the highly calcified stenotic artery, minimizing vessel injury. The case we described is the first case of lithoplasty applied to the CFA as the previous studies (PAD I and II) were focused on superficial femoral artery and popliteal lesions and some reports exist on iliac treatment. Although a recent paper showed positive results for stenting, CFA is usually considered not suitable for stenting consequently PTA in this segment needs to be very careful. In a retrospective analysis, Guo et al. have recently demonstrated that atherectomy might be better than angioplasty for CFA atherosclerotic obstructive lesions, especially in bifurcations. However, this technique might be limited by the high rates of dissection and consequent need for stenting. Angioplasty and provisional stenting were also compared in 96 patients undergoing isolated percutaneous revascularization of CFA. In more than one-third of patients undergoing angioplasty, stent placement became necessary, with a restenosis 14%. In our case, lithoplasty balloon was highly effective as shown by the pre- and post-procedural angiograms (Figures and ), and was safe as no early/late vascular complication occurred. Although larger studies are needed to confirm our result, peripheral lithoplasty seems a promising system for the treatment of highly calcified lesions not only in the superficial femoral artery and popliteal segments but also in CFA.

Lead author biography

Professor Carlo Trani is the Head of Cath Lab at Catholic University of the Sacred Heart in Rome.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: F.B. discloses to have been involved in advisory board meetings or having received speaker’s fees from Medtronic, St Jude Medical, Abiomed, and Biotronic. C.T. discloses to have been involved in advisory board meetings or having received speaker’s fees from St Jude Medical, Abiomed, and Biotronic. C.A. has been involved in advisory board activities by Biotronic. G.R. has no conflict of interest to declare. Click here for additional data file.
Past cardiovascular historyLeft superficial femoral artery percutaneous transluminal angioplasties + stenting and coronary artery bypass grafting
One month prior to admissionLeft lower limb pain at rest with severe activity restriction
In-hospital managementLithoplasty balloon angioplasty in common femoral artery
Six-month follow-upPatient still asymptomatic for limb pain and no activity restriction occurrence
  17 in total

1.  Stenting or Surgery for De Novo Common Femoral Artery Stenosis.

Authors:  Yann Gouëffic; Nellie Della Schiava; Fabien Thaveau; Eugenio Rosset; Jean-Pierre Favre; Lucie Salomon du Mont; Jean-Marc Alsac; Réda Hassen-Khodja; Thierry Reix; Eric Allaire; Eric Ducasse; Raphael Soler; Béatrice Guyomarc'h; Bahaa Nasr
Journal:  JACC Cardiovasc Interv       Date:  2017-07-10       Impact factor: 11.195

2.  Safety and Performance of Lithoplasty for Treatment of Calcified Peripheral Artery Lesions.

Authors:  Marianne Brodmann; Martin Werner; Todd J Brinton; Uday Illindala; Alexandra Lansky; Michael R Jaff; Andrew Holden
Journal:  J Am Coll Cardiol       Date:  2017-08-15       Impact factor: 24.094

3.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Authors:  Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-03-01       Impact factor: 29.983

4.  Lithoplasty-assisted transfemoral aortic valve implantation.

Authors:  Carlo Di Mario; Niccolò Chiriatti; Miroslava Stolcova; Francesco Meucci; Giovanni Squillantini
Journal:  Eur Heart J       Date:  2018-02-14       Impact factor: 29.983

5.  Directional Atherectomy Is Associated with Better Long-Term Efficiency Compared with Angioplasty for Common Femoral Artery Occlusive Disease in Rutherford 2-4 Patients.

Authors:  Jianming Guo; Lianrui Guo; Zhu Tong; Xixiang Gao; Zhonggao Wang; Yongquan Gu
Journal:  Ann Vasc Surg       Date:  2018-03-01       Impact factor: 1.466

Review 6.  Stent fracture in the coronary and peripheral arteries.

Authors:  Satjit Adlakha; Mujeeb Sheikh; Jason Wu; Mark W Burket; Utpal Pandya; William Colyer; Ehab Eltahawy; Christopher J Cooper
Journal:  J Interv Cardiol       Date:  2010-08       Impact factor: 2.279

7.  Use of the AngioSculpt scoring balloon for infrapopliteal lesions in patients with critical limb ischemia: 1-year outcome.

Authors:  Marc Bosiers; Koen Deloose; Catherine Cagiannos; Jürgen Verbist; Patrick Peeters
Journal:  Vascular       Date:  2009 Jan-Feb       Impact factor: 1.285

8.  Angioplasty and provisional stent treatment of common femoral artery lesions.

Authors:  Robert F Bonvini; Aljoscha Rastan; Sebastian Sixt; Ulrich Beschorner; Elias Noory; Thomas Schwarz; Marco Roffi; Pierre-André Dorsaz; Uwe Schwarzwälder; Karlheinz Bürgelin; Roland Macharzina; Thomas Zeller
Journal:  J Vasc Interv Radiol       Date:  2013-01-28       Impact factor: 3.464

9.  Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.

Authors:  Sebastian Sixt; Oscar Gerardo Carpio Cancino; András Treszl; Ulrich Beschorner; Roland Macharzina; Aljoscha Rastan; Hans Krankenberg; Franz-Josef Neumann; Thomas Zeller
Journal:  J Vasc Surg       Date:  2013-06-04       Impact factor: 4.268

10.  Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.

Authors:  Thomas Zeller; Ralf Langhoff; Krishna J Rocha-Singh; Michael R Jaff; Erwin Blessing; Beatrice Amann-Vesti; Marek Krzanowski; Patrick Peeters; Dierk Scheinert; Giovanni Torsello; Sebastian Sixt; Gunnar Tepe
Journal:  Circ Cardiovasc Interv       Date:  2017-09       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.